Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study

Fig. 2

Outcome of allogeneic stem cell transplantations in two cohorts after a median follow-up of 820 days. a Cumulative incidence of positive measurable/minimal residual disease after transplantation (overall P value for uni- and multivariate analysis was 0.024 and 0.018). b Cumulative incidence of leukemia relapse (overall P value for uni- and multivariate analysis was 0.008 and 0.001). c Non-relapse mortality (overall P value for uni- and multivariate analysis was 0.869 and 0.478). d Leukemia-free survival (overall P value for uni- and multivariate analysis was 0.025 and 0.001). e Overall survival (overall P value for uni- and multivariate analysis was 0.042 and 0.001). Abbreviations: Haplo-SCT, haploidentical stem cell transplantation; MSDT, human leukocyte antigen-matched sibling donor transplantation; MRD, measurable residual disease

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us